Dialysis Equipment Market
Dialysis Equipment Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Hemodialysis Equipment, Peritoneal Equipment, Continuous Renal Replacement Therapy (CRRT) Equipment, Dialysis Accessories
- By Modality In-Center Dialysis, Home Dialysis
- By Application Acute Kidney Injury (AKI) Treatment, End-Stage Renal Disease (ESRD) Management, Chronic Kidney Disease (CKD) Treatment
- By End-User Hospitals, Clinics, Research Laboratories, Home Healthcare Settings, Dialysis Centers
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2024 |
Forecast Years: | 2025 - 2034 |
Historical Years: | 2019 - 2023 |
Revenue 2024: | USD 20.94 Billion |
Revenue 2034: | USD 36.29 Billion |
Revenue CAGR (2025 - 2034): | 6.3% |
Fastest Growing Region (2025 - 2034) | Asia Pacific |
Largest Region (2024): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
The global dialysis equipment market size was USD 19.70 billion in 2023, and is calculated at USD 20.94 Billion in 2024. The market is projected to reach USD 36.29 Billion by 2034, and register a revenue 6.3% over the forecast period (2025-2034).
Premium Insights:
Global dialysis equipment market revenue growth has increased substantially over the last decade, with rising prevalence of chronic kidney disease (CKD), End-Stage Renal Disease (ESRD), diabetes-related nephropathy, hypertension-induced renal disorders, rapid aging of the global population and rising prevalence of age-related chronic diseases and conditions.
Over 850 million people globally are affected by chronic kidney disease, and according to World Health Organization (WHO), kidney diseases have risen from the world’s nineteenth leading cause of death to ninth position, with number of deaths increasing by 95% between 2000 and 2024. Also, the number of individuals with kidney disease is double that of persons with diabetes, and 20-times that of persons with cancer or AIDS/HIV. In addition, CKD is more common in women, older people, and racial minorities, and also more prevalent in people with diabetes or hypertension. As of 2023 data, Taiwan, Japan, Mexico, the United States (US), and Belgium have highest prevalence rates of kidney failure. In the US alone, one in seven adults, or 37 million individuals have been diagnosed with the condition, among which, around 700,000 individuals are estimated to have End-Stage Kidney Disease (ESKD).
As the prevalence rates of kidney diseases and conditions increase, the demand for dialysis equipment and need for treatment rises simultaneously. Dialysis is critical for individuals with failing kidneys, and these devices and equipment filter wastes, excess fluid, and toxins from the bloodstream, without which outcomes are always fatal in time. Hemodialysis and peritoneal dialysis systems and machines continue to register significantly high demand, along with rising prevalence rates and increasingly younger sufferers reporting conditions such as Acute Kidney Injury (AKI) and renal failure. Among a sizable patient pool with kidney disease requiring dialysis, contributing factors reported include diabetes, hypertension, and glomerulonephritis.
Demand for in-center hemodialysis, Home Hemodialysis (HHD) therapy, and peritoneal dialysis continue to incline, with demand for home-based and patient-friendly dialysis equipment rapidly gaining preference due to convenience and autonomy in treatments. Technological advancements and innovations in equipment and systems has been resulting in introduction of new and more efficient, smart, and advanced dialysis devices. Advancements in wearable and portable dialysis devices and machines have been driving major changes and gaining traction, while automated systems that reduce the need for clinical supervision and emergence of biocompatible dialysis membranes that enhance patient comfort are gaining steady traction in the dialysis equipment market.
Other driving factors include flexible healthcare reimbursement policies and cover, increasing trend of preventive healthcare, governmental and non-governmental entities driving initiatives focused on prevention/early detection of kidney disease, emphasizing the critical role of access to therapies and diagnosis​easy, enabling access to healthcare and specialists, and companies developing and seeking approval for a wide range of equipment and developing more cost-effective options.
Dialysis Equipment Market Size, 2024 To 2034 (USD Billion)
AI (GPT) is here !!! Ask questions about Dialysis Equipment Market
Top Dialysis Equipment Market Drivers and Trends:
- High Prevalence of CKD and ESRD: Prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) continues to rise and drive need for treatment and care for patients. Further contributing to increasing prevalence are prevalence of diabetes and hypertension, which among others, are leading causes of kidney failure. Rapidly aging population globally is also driving demand for renal care and dialysis treatments, and in turn supporting revenue growth of the dialysis equipment market.
- R&D, Technological Advancements, and Innovations: Manufacturers and research organizations are focusing on technology to aid in development of more efficient and safer dialysis equipment and devices. This trend remains continuous, and major focus is being given to functionality and accessibility of dialysis equipment. Companies are also engaged in development of more user-friendly and portable dialysis machines, wearable devices, and home-based dialysis solutions to cater to need for patient convenience, mobility, ease of use, and also focusing on improving compliance, and approaches and features in equipment to reduce strain on healthcare facilities. Automated dialysis systems and biocompatible dialysis membranes continue to gain traction across the healthcare sector, and are serving to improve patient outcomes, reduce manual intervention, and offer safer, and more efficient treatments.
- Supportive Government Initiatives: Supportive government initiatives and reimbursement policies are also supporting growth of the dialysis equipment market. These initiatives are enabling easier accessibility to dialysis treatments, and this is relevant especially in some developing economies. Investment and government support for initiatives and programs to promote and encourage early detection, diagnosis, and treatment of various chronic diseases and health conditions are also serving to drive expansion of healthcare infrastructure and modernization of facilities and offerings. This is also supporting demand for new equipment and systems, including equipment and systems for treating patients with CVD and ESRD, among other conditions and diseases.
- Use of Dialysis to Delay Kidney Disease Progression: Increasing awareness regarding the benefits of early diagnosis and use of dialysis and treatment to slow down, manage, and delay progression of CKD, while improving quality of life, is a trend that is gaining traction in the healthcare sector. The trend toward home dialysis, increasing patient preference for portable and wearable devices, and continued advancements in biotechnology are further driving adoption of dialysis equipment across various end-use applications.
Dialysis Equipment Market Restraining Factor Insights
- High Equipment Costs and Affordability Challenges: Charges for treatment in healthcare facilities and use of dialysis equipment can be extremely high cost, especially for patients in some emerging and developing economies, and for those without adequate medical insurance or cover. The cost and affordability factors can impact decision to purchase or upgrade existing equipment in healthcare facilities and hospitals in such situations. Cost is a major factor in healthcare facilities and organizations, and the initial purchase price of advanced dialysis machines, as well as maintenance, and consumables including filters and dialysis fluids can be a significantly major financial burden. This is further magnified by the low number of patients with capacity to afford treatments in such hospitals, as well as the lean patient pool not compensating or enabling Return on Investment (ROI) for such equipment.
- Research and Development Challenges: Innovation is crucial and R&D in dialysis technology is costly and time-consuming. Developing new, more efficient machines with enhanced safety features requires substantial investment, and regulatory approval processes can further delay product launches. These challenges may slow down the pace of technological advancements, and can have a negative impact on investors and interest in new equipment.
- Inconvenience and Disadvantages of Use: Dialysis, especially hemodialysis, is a time-consuming and often uncomfortable process. Patients must undergo frequent, lengthy sessions, typically three times per week, which disrupts daily life. This inconvenience can lead to lower compliance rates and reduced adoption of dialysis treatments.
- Availability of Alternative Treatments: As kidney transplants and regenerative medicine improve, some patients opt for transplants over long-term dialysis. Artificial kidneys and advancements in stem cell therapy are seen as potential future alternatives to dialysis, which can potentially reduce demand.
Dialysis Equipment Market Opportunities
- Geographic Expansion: Leading companies can leverage emerging opportunities and create additional revenue streams by expanding into emerging markets. Demand for dialysis equipment continues to rise steadily, and this is consistent with rising prevalence rates of chronic kidney disease. However, availability of more recent and advanced equipment is not available in a number of developing economies and markets, and this presents major avenues for growth. Building distribution networks, partnering with local healthcare providers, and advocating for government policies that support renal care, while expanding into such untapped markets can expand revenue streams while addressing unmet healthcare needs.
- Investment in R&D for Improved Equipment: Investing in research and development for new and improved dialysis technologies can lead to product differentiation and increased market share. Manufacturers can focus on developing next-generation devices, such as wearable and portable dialysis machines, that serve patients as more convenient, home-based treatment options. Collaborating with medical professionals and regulatory bodies to drive innovation and comply with increasingly stringent safety standards can speed up product development and approval processes, thereby enabling faster market entry.
- Mergers and Acquisitions: Entering into strategic mergers, acquisitions, and partnerships can prove beneficial and open up avenues for market consolidation and expansion. Acquisition of smaller companies or entering into alliances with medical device firms and dialysis equipment manufacturers can open access to new technologies, expand product portfolios, and strengthen market presence.
Dialysis Equipment Market Segmentation:
By Product:
- Hemodialysis Equipment
- Peritoneal Equipment
- Continuous Renal Replacement Therapy (CRRT) Equipment
- Dialysis Accessories
By Modality:
- In-Center Dialysis
- Home Dialysis
By Application:
- Acute Kidney Injury (AKI) Treatment
- End-Stage Renal Disease (ESRD) Management
- Chronic Kidney Disease (CKD) Treatment
By End-User:
- Hospitals
- Clinics
- Research Laboratories
- Home Healthcare Settings
- Dialysis Centers
Segment Insights:
By Product:
The hemodialysis equipment segment is expected to account for relatively larger revenue share compared to the peritoneal dialysis equipment segment over the forecast period. This can be attributed to hemodialysis being more commonly and widely used for patients with chronic kidney diseases and end-stage renal disease, as the treatment can be performed in a clinical setting under medical supervision. This is also the standard treatment for managing advanced kidney failure, and also demand for this equipment is relatively high in hospitals and dialysis centers. In addition, hemodialysis equipment have been undergoing significant advancements, including development and introduction of home-use devices. The innovation and convenience offered by such systems adds to appeal due to flexibility, reduced need to visit clinics, and these systems have been gaining acceptance among an increasing number of patients. Automation is another key factor, and automated equipment and systems offer improved efficiency and enhanced patient safety. Favorable government policies and reimbursement for hemodialysis treatments, especially in developed regions, position these systems as more accessible to patients, thereby attracting a wider consumer base. Also, increasing patient pool for treatment due to rising prevalence of chronic kidney diseases and end-stage renal failure is expected to continue to support revenue growth of the hemodialysis equipment segment.
By Modality:
Among the modality segments in the global dialysis equipment market, the in-center dialysis segment is expected to account for largest revenue share over the forecast period. This can be attributed to in-center dialysis capacity to cater to patients with more complex needs and also for those at initial stage or starting dialysis treatment, wherein close monitoring and professional support can be provided. Also, in-center facilities can handle greater patient volume and demand for dialysis equipment is consistent from such facilities. In addition, provision of comprehensive care, including access to trained healthcare professionals, immediate medical attention, and a controlled environment for treatments position in-center dialysis in high appeal.
By Application:
Among the application segments in the global dialysis equipment market, the end-stage renal disease (ESRD) management segment is expected to account for largest revenue share over the forecast period. High prevalence of ESRD is driven by rising prevalence of chronic kidney disease and this is a key catalyst for rising demand for dialysis treatments and equipment. Dialysis is crucial for managing ESRD and enhancing quality of life of patient, and is also considered as a life-saving treatment option for patients whose kidneys can no longer filter waste from the blood effectively. Government support and reimbursement policies that prioritize renal care, particularly for ESRD patients, and initiatives encouraging early diagnosis and treatment are also key factors expected to continue to support growth of this segment.
Report Coverage & Deliverables
Get Access Now
Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point
By End-User:
Among the end-user segments in the global dialysis equipment market, the dialysis centers segment is expected to account for largest revenue share over the forecast period. This projection can be attributed to availability of specialized infrastructure and expertise at dialysis centers and focused delivery of dialysis treatments. Also, such facilities are designed to handle a high volume of patients and provide both in-center hemodialysis and home dialysis training, making them a primary choice for patients requiring ongoing care. Another factor driving growth of this segment is rising patient volumes driven by increasing prevalence of chronic kidney disease and end-stage renal disease, and capability of dialysis centers to cater to needs of a large number of patients, and to provide routine dialysis treatments on a regular basis. These factors are also encouraging increasing deployment of such centers, which is also driving demand for dialysis equipment. Dialysis centers also offer more cost-effective and convenient services for patients, especially centers in developed countries where healthcare systems and insurance and reimbursement are well established.
Regions and Countries
North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- United Arab Emirates
- Israel
- Rest of MEA
Dialysis Equipment Market Regional Landscape:
Among the regional markets in the global dialysis equipment market, North America leads in terms of revenue share, and the trend is expected to continue over the forecast period. The US accounts for majority revenue share due to well-established healthcare infrastructure, extensive dialysis services, adequate reimbursement policies for dialysis treatments, and high prevalence of chronic kidney diseases. In Europe, Germany and the UK lead in terms of revenue share owing to robust healthcare systems and rising prevalence of kidney diseases, aging population, and increased focus on kidney health.
Rapid revenue growth of the Asia Pacific dialysis equipment market is driven by high contribution from Japan, India, and China, which have large and expanding patient populations, and also due to rising investments in healthcare. Latin America is also expected to register steady growth over the forecast period, with Brazil and Mexico remaining key markets due to initiatives by governments to improve healthcare infrastructure and enhance accessibility to services and treatments.
Dialysis Equipment Market Competitive Landscape:
Company List:
- Fresenius Medical Care AG & Co. KGaA
- DaVita Inc.
- Baxter International Inc.
- B. Braun Melsungen AG
- Asahi Kasei Corporation
- Medtronic plc
- Nikkiso Co., Ltd.
- NIPRO Corporation
- JMS Co., Ltd.
- Toray Industries, Inc.
- Becton, Dickinson and Company (BD)
- Dialife
- Ecolab
- Cantel Medical Corp
- Rockwell Medical Inc.
Competitive Landscape:
The competitive landscape in the global dialysis equipment market is characterized by a mix of established players and emerging companies focused on innovation and technological advancements to offer more efficient and cost-effective equipment and systems on the global market. Major companies, such as Fresenius Medical Care, Baxter International, and B. Braun Melsungen AG, dominate the market due to their extensive product portfolios, strong distribution networks, and significant investments in research and development.
Primary strategies include product innovation, focus on developing advanced dialysis technologies, such as portable and home dialysis systems that enhance patient convenience and comfort. This shift toward more user-friendly equipment allows companies to cater to the growing demand for home-based treatment options. In addition, companies are emphasizing strategic partnerships and collaborations with healthcare providers and research institutions to improve access to their products and develop new solutions that meet evolving patient needs.
Moreover, companies are leveraging geographic expansion into emerging markets, where rising healthcare investments and increasing awareness of kidney diseases present lucrative opportunities. By tailoring their offerings to local needs and forming alliances with local healthcare systems, companies can effectively penetrate these markets.
Recent Developments
- September 4, 2024: Fresenius Medical Care (FME), which is a global leader in kidney care, announced it achieved a growth milestone of over 14,000 US-based patients using its NxStage systems to perform Home Hemodialysis (HHD) therapy through both Fresenius Kidney Care clinics and other providers. In parallel, FME has also launched the newest version of its home dialysis machine, the NxStage Versi HD with GuideMe Software, featuring enhancements designed to simplify treatment, increase ease of learning, and improve user experience. The company has recorded an 18% increase in number of HDD patients starting treatment with NxStage in the US between January and April 2024 compared to same period in 2023. In April 2022, the company announced securing US Food and Drug Administration (FDA) 510(k) clearance for its Versi PD Cycler System1, which is a portable automated peritoneal dialysis cycler.
- May 8, 2024: Outset Medial Inc. announced receiving FDA 510(k) clearance of TabloCart with Prefiltration, which is an optional accessory for the Tablo Hemodialysis System. The TabloCart is a single solution device intended to streamline and make dialysis treatment more accessible, and comes in two versions, including one with added storage and one with water prefiltration capabilities. The announcement notice comes after Outset paused shipment of the device in August 2023 pending FDA clearance for marketing authorization, but has now resumed distribution in the US
Frequently Asked Questions:
Q: What is the global dialysis equipment market size in 2023 and what is the projection for 2034?
A: The global dialysis equipment market size was USD 19.70 billion in 2023 and expected to reach USD 36.29 billion in 2034.
Which regional market accounted for largest revenue share in 2023, and what is the expected trend over the forecast period?
A: North America accounted for largest revenue share in 2023, and is also expected to continue to maintain its lead over the forecast period.
Q: Which are the major companies are included in the global dialysis equipment market report?
A: Major companies in the market report are Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International Inc., B. Braun Melsungen AG, Asahi Kasei Corporation, Medtronic plc, Nikkiso Co., Ltd., NIPRO Corporation, JMS Co., Ltd., Toray Industries, Inc., Becton, Dickinson and Company (BD), Dialife, Ecolab, Cantel Medical Corp, Rockwell Medical Inc.
Q: What is the projected revenue CAGR of the global dialysis equipment market over the forecast period?
A: The global dialysis equipment market is expected to register a CAGR of 6.3% between 2025 and 2034.
Q: What are some key factors driving revenue growth of the dialysis equipment market?
A: Some key factors driving market revenue growth include rising prevalence of chronic kidney disease (CKD), End-Stage Renal Disease (ESRD), diabetes-related nephropathy, hypertension-induced renal disorders, rapid aging of the global population, and rising prevalence of age-related chronic diseases and conditions.
FAQ
Frequently Asked Question
What is the global demand for Dialysis Equipment in terms of revenue?
-
The global Dialysis Equipment valued at USD 20.94 Billion in 2024 and is expected to reach USD 36.29 Billion in 2034 growing at a CAGR of 6.3%.
Which are the prominent players in the market?
-
The prominent players in the market are Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International Inc., B. Braun Melsungen AG, Asahi Kasei Corporation, Medtronic plc, Nikkiso Co., Ltd., NIPRO Corporation, JMS Co., Ltd., Toray Industries, Inc., Becton, Dickinson and Company (BD), Dialife, Ecolab, Cantel Medical Corp, Rockwell Medical Inc..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.3% between 2025 and 2034.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Dialysis Equipment include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Dialysis Equipment in 2024.